Covid Vaccines May Only Stop Covid Symptoms: Yuen

"); jQuery("#212 h3").html("

Related News Programmes

"); });

2020-12-25 HKT 13:52

Share this story

facebook

  • Yuen Kwok-yung and his research team analyse the three coronavirus vaccines procured by the government in a newspaper article. Photo: RTHK

    Yuen Kwok-yung and his research team analyse the three coronavirus vaccines procured by the government in a newspaper article. Photo: RTHK

Government adviser Yuen Kwok-yung said on Friday that the three types of coronavirus vaccines procured by the government may not be able to help Hong Kong avoid asymptomatic infections, but he stressed there is still an urgent need for everyone to get inoculated.

The University of Hong Kong microbiologist explained that early lab tests showed the vaccines could trigger the production of neutralizing antibodies to prevent a person from developing symptoms or complications after being infected, but they could not stop a person from releasing the virus and infecting others.

Still, Yuen highlighted that efforts to help Hong Kong develop herd immunity should get underway as soon as possible.

"There is an imminent need to launch a universal innoculation programme," Yuen wrote with his research team in the Chinese-language Ming Pao newspaper.

Yuen, who is a member of the government's independent advisory panel on Covid-19 vaccines, also suggested that vaccines produced by Fosun-BioNtech and the mainland's Sinovac could be better options to be introduced in Hong Kong first.

He noted that trial results out so far for the Sinovac vaccine showed that it carries the fewest side-effects, but is expected to offer a shorter protection period.

But he stressed that the government must wait for Sinovac's late-stage trial results, which will not be released until next month after a delay, and conduct a thorough analysis before deciding to use its vaccine.

As for the vaccine developed by Fosun and BioNTech, Yuen said clinical trials showed that it is relatively safe and also offers good protection.

But he said it is necessary to observe the third option by Oxford University and AstraZeneca for a longer period of time for any side effects, noting that two people who earlier received the jabs had developed a neurological disorder.

Yuen urged the government to boost public confidence in inoculating against the coronavirus by being transparent.

"The inoculation scheme must aim to be quick, widespread, open and with choices for people to pick," he said.

RECENT NEWS

HashKey Capital Partners With Tiantu AM To Explore Virtual Asset Funds

HashKey Capital has signed a memorandum of strategic collaboration with Tiantu Asset Management (Tiantu AM), a wholly o... Read more

You Can Now Make Alipay Payments With AR Glasses

RayNeo and Ant Group have announced a partnership to develop digital payment solutions for global use. The collaboratio... Read more

JICA Goes Live With Finastras Loan IQ In First Japan Deployment

Finastra has announced that the Japan International Cooperation Agency (JICA) has gone live with its Loan IQ platform. ... Read more

Japan Set To Approve First Yen-Backed Stablecoin

Japan’s Financial Services Agency (FSA) is preparing to approve the issuance of the country’s first yen-backed stab... Read more

Indonesia And China Begin Trials For Cross-Border QRIS Payments

Bank Indonesia (BI) and the People’s Bank of China (PBOC) have begun a series of trials for cross-border QR code paym... Read more

ANZ Appoints Ender Tanar As Japan Country Head

ANZ, headquartered in Melbourne, Australia, announced the appointment of Ender Tanar as Country Head for Japan, reporti... Read more